PFSmanufacturingprocessforbiotech生物制剂用预灌封注射.PDF
文本预览下载声明
PFS manufacturing process for biotech
生物制剂用预灌封注射器 制造工艺
Alessandro Morandotti, Product Manager Syringes
欧璧注射器产品经理 Alessandro Morandotti
CNPPA,2016 年 9 月 9 日
Outline
大纲
• Market overview (up to date and in the next 5 years)
市场概览 (最新及未来5 年)
• Market evolution 市场发展
• Syringe Segmentation 注射器细分
• Injectable trend 注射剂趋势
• PFS and sensitive drugs:
预灌封注射器和敏感药物:
• Existing technical challenges aspect to be considered during development
of PFS:预充针开发过程中要考虑的现有技术难题:
• Silicone treatment (silicone quantity and components selection)
硅化处理(硅油量和配件选择)
• Autoinjectors integration 自动注射笔适配组装
• New option for high sensitive drugs 高敏感药物的新选择
• State of the art manufacturing process and control strategy
尖端制造工艺与控制策略
2
Trends: injectables blockbuster
趋势:注射剂迅速发展
注射剂需求至2018年均复合增长率达4%-7%
3
Worldwide Market Trend on Injectable Drugs
注射剂药物全球市场趋势
+3 bn of More
PFS on the Self-Administration safety
market 自我给药 更加
市面现有 安全
+30 亿 预充针
PFS are widely used for Responsibilities are transferred Increasing standards are
administering vaccines, to Patient or Caregiver driving demand for high
heparin, biotech drugs (easy-of use and compliance quality products also in
预充针广泛用于疫苗、肝素 as consequence) emerging markets
和生物技术药物给药 职责转移至患者或看护人员
显示全部